IPO5P1 has not been reported in gastric cancer, but bioinformatics studies imply that IPO5P1 is a prognostic factor in bladder cancer and correlates with the effects of immunotherapy [40]. The gene discussed is IPO5P1; the disease is urinary bladder carcinoma.